Renovion, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.renovion.com
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Phase 3
Recruiting
- Conditions
- Pre-Bronchiolitis Obliterans Syndrome
- Interventions
- Other: Standard of care only
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Renovion, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05654922
- Locations
- 🇺🇸
Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸University of California Los Angeles School of Medicine, Los Angeles, California, United States
🇺🇸University of California San Diego Health, San Diego, California, United States
Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Renovion, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05495243
- Locations
- 🇺🇸
Louisiana State University, New Orleans, Louisiana, United States
🇺🇸Georgetown University, Washington, District of Columbia, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath